Article Detail - JF Part A
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58681) - R6 - Effective August 1, 2024
Date Posted: August 1, 2024
This coverage article has been revised and published for notice under contract numbers: 02101 (AK), 02201 (ID), 02301 (OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY).
Effective Date: August 1, 2024
Summary of Article Changes:
Under ICD-10 Codes that Support Medical Necessity Group 1: Codes deleted K63.5. Added C23, C24.1, C24.8, C48.0, C53.8, C67.0, C67.1, C67.2, C67.3, C67.4, C67.5, C67.6, C67.7, C67.8, C67.9, C79.11, D00.2, D01.0, D01.1, D01.2, D01.40, D01.49, D01.5, D01.7, D05.00, D05.01, D05.02, D05.10, D05.80, D05.81, D05.82, D05.90, D05.91, D05.92, D06.0, D06.1, D07.0, D07.5, D09.3, D09.8, Z85.51, Z86.001, Z86.002, and Z86.004.
Visit the Noridian Billing and Coding Articles webpage to view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.
